ID   AGRB1_RAT               Reviewed;        1577 AA.
AC   C0HL12;
DT   25-OCT-2017, integrated into UniProtKB/Swiss-Prot.
DT   25-OCT-2017, sequence version 1.
DT   24-JUL-2024, entry version 31.
DE   RecName: Full=Adhesion G protein-coupled receptor B1 {ECO:0000312|RGD:1305608};
DE   AltName: Full=Brain-specific angiogenesis inhibitor 1 {ECO:0000312|RGD:1305608};
DE   Contains:
DE     RecName: Full=Vasculostatin-120 {ECO:0000250|UniProtKB:O14514};
DE              Short=Vstat120 {ECO:0000250|UniProtKB:O14514};
DE   Contains:
DE     RecName: Full=Vasculostatin-40 {ECO:0000250|UniProtKB:O14514};
DE              Short=Vstat-40 {ECO:0000250|UniProtKB:O14514};
DE   Flags: Precursor;
GN   Name=Adgrb1 {ECO:0000312|RGD:1305608};
GN   Synonyms=Bai1 {ECO:0000312|RGD:1305608};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway {ECO:0000303|PubMed:15057822};
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [2]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [3] {ECO:0000305}
RP   FUNCTION, INTERACTION WITH PARD3 AND TIAM1, AND SUBCELLULAR LOCATION.
RX   PubMed=23595754; DOI=10.1523/jneurosci.3978-12.2013;
RA   Duman J.G., Tzeng C.P., Tu Y.K., Munjal T., Schwechter B., Ho T.S.,
RA   Tolias K.F.;
RT   "The adhesion-GPCR BAI1 regulates synaptogenesis by controlling the
RT   recruitment of the Par3/Tiam1 polarity complex to synaptic sites.";
RL   J. Neurosci. 33:6964-6978(2013).
CC   -!- FUNCTION: Phosphatidylserine receptor which enhances the engulfment of
CC       apoptotic cells (By similarity). Also mediates the binding and
CC       engulfment of Gram-negative bacteria (By similarity). Stimulates
CC       production of reactive oxygen species by macrophages in response to
CC       Gram-negative bacteria, resulting in enhanced microbicidal macrophage
CC       activity (By similarity). In the gastric mucosa, required for
CC       recognition and engulfment of apoptotic gastric epithelial cells (By
CC       similarity). Promotes myoblast fusion (By similarity). Activates the
CC       Rho pathway in a G-protein-dependent manner (By similarity). Inhibits
CC       MDM2-mediated ubiquitination and degradation of DLG4/PSD95, promoting
CC       DLG4 stability and regulating synaptic plasticity (By similarity).
CC       Required for the formation of dendritic spines by ensuring the correct
CC       dendritic localization of PARD3 and TIAM1 (PubMed:23595754). Potent
CC       inhibitor of angiogenesis in brain and may play a significant role as a
CC       mediator of the p53/TP53 signal in suppression of glioblastoma (By
CC       similarity). {ECO:0000250|UniProtKB:O14514,
CC       ECO:0000269|PubMed:23595754}.
CC   -!- FUNCTION: [Vasculostatin-120]: Inhibits angiogenesis in a CD36-
CC       dependent manner. {ECO:0000250|UniProtKB:O14514}.
CC   -!- FUNCTION: [Vasculostatin-40]: Inhibits angiogenesis.
CC       {ECO:0000250|UniProtKB:O14514}.
CC   -!- SUBUNIT: Interacts with ELMO1 and DOCK1 (By similarity). When bound to
CC       ELMO1 and DOCK1, acts as a module to promote apoptotic cell engulfment
CC       (By similarity). Interacts with MDM2; the interaction results in
CC       inhibition of MDM2-mediated ubiquitination and degradation of
CC       DLG4/PSD95 (By similarity). Interacts with PARD3 and TIAM1; the
CC       interaction is required for correct dendritic localization of PARD3 and
CC       TIAM1 and for dendritic spine formation (PubMed:23595754). Interacts
CC       with MAGI1, MAGI3 and BAIAP2 (By similarity). Interacts with PHYHIP (By
CC       similarity). Interacts with DLG4 (via PDZ domain) (By similarity).
CC       Vasculostatin-120: Interacts with CD36 (By similarity). Vasculostatin-
CC       120: Interacts with ARRB2 (By similarity). Interacts with BAIAP3; this
CC       interaction is direct (By similarity). {ECO:0000250|UniProtKB:O14514,
CC       ECO:0000250|UniProtKB:Q3UHD1}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:O14514};
CC       Multi-pass membrane protein {ECO:0000255}. Cell projection, phagocytic
CC       cup {ECO:0000250|UniProtKB:Q3UHD1}. Cell junction, focal adhesion
CC       {ECO:0000250|UniProtKB:Q3UHD1}. Cell projection, dendritic spine
CC       {ECO:0000269|PubMed:23595754}. Postsynaptic density
CC       {ECO:0000269|PubMed:23595754}.
CC   -!- SUBCELLULAR LOCATION: [Vasculostatin-120]: Secreted
CC       {ECO:0000250|UniProtKB:O14514}.
CC   -!- SUBCELLULAR LOCATION: [Vasculostatin-40]: Secreted
CC       {ECO:0000250|UniProtKB:O14514}.
CC   -!- DOMAIN: The TSP type-1 repeats in the extracellular domain mediate
CC       binding to phosphatidylserine. They are also required for bacterial
CC       recognition and binding to bacterial outer membrane lipopolysaccharide.
CC       {ECO:0000250|UniProtKB:Q3UHD1}.
CC   -!- PTM: Proteolytically cleaved to produce vasculostatin-40 and
CC       vasculostatin-120. Vasculostatin-40 is the major form and is produced
CC       through proteolytic cleavage by MMP14 between residues 317 and 325 with
CC       cleavage likely to be between Ser-322 and Leu-323.
CC       {ECO:0000250|UniProtKB:O14514}.
CC   -!- PTM: Ubiquitinated. {ECO:0000250|UniProtKB:O14514}.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 2 family. LN-TM7
CC       subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AABR07058422; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001164068.2; NM_001170597.2.
DR   AlphaFoldDB; C0HL12; -.
DR   SMR; C0HL12; -.
DR   GlyCosmos; C0HL12; 1 site, No reported glycans.
DR   GlyGen; C0HL12; 1 site.
DR   iPTMnet; C0HL12; -.
DR   PhosphoSitePlus; C0HL12; -.
DR   GeneID; 362931; -.
DR   KEGG; rno:362931; -.
DR   AGR; RGD:1305608; -.
DR   CTD; 575; -.
DR   RGD; 1305608; Adgrb1.
DR   InParanoid; C0HL12; -.
DR   OrthoDB; 4181250at2759; -.
DR   PRO; PR:C0HL12; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0030425; C:dendrite; ISO:RGD.
DR   GO; GO:0043197; C:dendritic spine; IEA:UniProtKB-SubCell.
DR   GO; GO:0005615; C:extracellular space; ISO:RGD.
DR   GO; GO:0005925; C:focal adhesion; ISO:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISO:RGD.
DR   GO; GO:0001891; C:phagocytic cup; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0014069; C:postsynaptic density; ISO:RGD.
DR   GO; GO:0045211; C:postsynaptic membrane; IDA:SynGO.
DR   GO; GO:0004930; F:G protein-coupled receptor activity; ISO:RGD.
DR   GO; GO:0001530; F:lipopolysaccharide binding; ISO:RGD.
DR   GO; GO:0030165; F:PDZ domain binding; ISO:RGD.
DR   GO; GO:0001786; F:phosphatidylserine binding; ISO:RGD.
DR   GO; GO:0004888; F:transmembrane signaling receptor activity; ISO:RGD.
DR   GO; GO:0007189; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0043277; P:apoptotic cell clearance; ISO:RGD.
DR   GO; GO:0007166; P:cell surface receptor signaling pathway; IEA:InterPro.
DR   GO; GO:0050829; P:defense response to Gram-negative bacterium; ISO:RGD.
DR   GO; GO:0043652; P:engulfment of apoptotic cell; ISO:RGD.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0007517; P:muscle organ development; IEA:UniProtKB-KW.
DR   GO; GO:0016525; P:negative regulation of angiogenesis; ISO:RGD.
DR   GO; GO:0010596; P:negative regulation of endothelial cell migration; ISO:RGD.
DR   GO; GO:0042177; P:negative regulation of protein catabolic process; ISO:RGD.
DR   GO; GO:0031397; P:negative regulation of protein ubiquitination; ISO:RGD.
DR   GO; GO:0007399; P:nervous system development; IEA:UniProtKB-KW.
DR   GO; GO:0006911; P:phagocytosis, engulfment; ISO:RGD.
DR   GO; GO:0006910; P:phagocytosis, recognition; ISO:RGD.
DR   GO; GO:1901741; P:positive regulation of myoblast fusion; ISO:RGD.
DR   GO; GO:1903428; P:positive regulation of reactive oxygen species biosynthetic process; ISO:RGD.
DR   GO; GO:0051965; P:positive regulation of synapse assembly; ISO:RGD.
DR   GO; GO:0098974; P:postsynaptic actin cytoskeleton organization; IDA:SynGO.
DR   GO; GO:0048167; P:regulation of synaptic plasticity; ISO:RGD.
DR   CDD; cd15251; 7tmB2_BAI_Adhesion_VII; 1.
DR   Gene3D; 1.25.40.610; -; 1.
DR   Gene3D; 2.60.220.50; -; 1.
DR   Gene3D; 4.10.1240.10; GPCR, family 2, extracellular hormone receptor domain; 1.
DR   Gene3D; 1.20.1070.10; Rhodopsin 7-helix transmembrane proteins; 1.
DR   Gene3D; 2.20.100.10; Thrombospondin type-1 (TSP1) repeat; 5.
DR   InterPro; IPR043838; AGRB_N.
DR   InterPro; IPR032471; GAIN_dom_N.
DR   InterPro; IPR046338; GAIN_dom_sf.
DR   InterPro; IPR017981; GPCR_2-like_7TM.
DR   InterPro; IPR008077; GPCR_2_brain_angio_inhib.
DR   InterPro; IPR036445; GPCR_2_extracell_dom_sf.
DR   InterPro; IPR001879; GPCR_2_extracellular_dom.
DR   InterPro; IPR000832; GPCR_2_secretin-like.
DR   InterPro; IPR000203; GPS.
DR   InterPro; IPR000884; TSP1_rpt.
DR   InterPro; IPR036383; TSP1_rpt_sf.
DR   PANTHER; PTHR12011:SF39; ADHESION G PROTEIN-COUPLED RECEPTOR B1; 1.
DR   PANTHER; PTHR12011; ADHESION G-PROTEIN COUPLED RECEPTOR; 1.
DR   Pfam; PF00002; 7tm_2; 1.
DR   Pfam; PF19188; AGRB_N; 1.
DR   Pfam; PF16489; GAIN; 1.
DR   Pfam; PF01825; GPS; 1.
DR   Pfam; PF02793; HRM; 1.
DR   Pfam; PF00090; TSP_1; 5.
DR   PRINTS; PR01694; BAIPRECURSOR.
DR   PRINTS; PR00249; GPCRSECRETIN.
DR   PRINTS; PR01705; TSP1REPEAT.
DR   SMART; SM00303; GPS; 1.
DR   SMART; SM00008; HormR; 1.
DR   SMART; SM00209; TSP1; 5.
DR   SUPFAM; SSF82895; TSP-1 type 1 repeat; 5.
DR   PROSITE; PS50227; G_PROTEIN_RECEP_F2_3; 1.
DR   PROSITE; PS50261; G_PROTEIN_RECEP_F2_4; 1.
DR   PROSITE; PS50221; GAIN_B; 1.
DR   PROSITE; PS50092; TSP1; 5.
PE   1: Evidence at protein level;
KW   Cell junction; Cell membrane; Cell projection; Disulfide bond;
KW   G-protein coupled receptor; Glycoprotein; Immunity; Innate immunity;
KW   Membrane; Myogenesis; Neurogenesis; Phagocytosis; Phosphoprotein; Receptor;
KW   Reference proteome; Repeat; Secreted; Signal; Synapse; Transducer;
KW   Transmembrane; Transmembrane helix; Ubl conjugation.
FT   SIGNAL          1..33
FT                   /evidence="ECO:0000255"
FT   CHAIN           34..1577
FT                   /note="Adhesion G protein-coupled receptor B1"
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_0000441808"
FT   CHAIN           34..923
FT                   /note="Vasculostatin-120"
FT                   /evidence="ECO:0000250|UniProtKB:O14514"
FT                   /id="PRO_0000441810"
FT   CHAIN           34..?323
FT                   /note="Vasculostatin-40"
FT                   /evidence="ECO:0000250|UniProtKB:O14514"
FT                   /id="PRO_0000441809"
FT   TOPO_DOM        34..944
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        945..965
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        966..976
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        977..997
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        998..1004
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1005..1025
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1026..1048
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1049..1069
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1070..1089
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1090..1110
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1111..1132
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1133..1153
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1154..1162
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1163..1183
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1184..1577
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   DOMAIN          257..311
FT                   /note="TSP type-1 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DOMAIN          350..403
FT                   /note="TSP type-1 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DOMAIN          405..458
FT                   /note="TSP type-1 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DOMAIN          463..516
FT                   /note="TSP type-1 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DOMAIN          518..571
FT                   /note="TSP type-1 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DOMAIN          756..935
FT                   /note="GAIN-B"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00098"
FT   REGION          310..331
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          880..935
FT                   /note="GPS"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00098"
FT   REGION          927..943
FT                   /note="N-terminal stalk following vasculostatin-120
FT                   cleavage which is not required for signaling activity"
FT                   /evidence="ECO:0000250|UniProtKB:O14514"
FT   REGION          1359..1577
FT                   /note="Involved in interaction with MAGI1"
FT                   /evidence="ECO:0000250|UniProtKB:O14514"
FT   REGION          1378..1469
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1499..1544
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1574..1577
FT                   /note="Indispensable for interaction with MAGI1"
FT                   /evidence="ECO:0000250|UniProtKB:O14514"
FT   COMPBIAS        1385..1429
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1445..1464
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1499..1536
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   SITE            922..923
FT                   /note="Cleavage"
FT                   /evidence="ECO:0000250|UniProtKB:O14514"
FT   MOD_RES         605
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:O14514"
FT   MOD_RES         1462
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3UHD1"
FT   CARBOHYD        877
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        269..305
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DISULFID        273..310
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DISULFID        284..295
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DISULFID        362..396
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DISULFID        366..402
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DISULFID        377..386
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DISULFID        417..452
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DISULFID        421..457
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DISULFID        432..442
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DISULFID        475..510
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DISULFID        479..515
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DISULFID        490..500
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DISULFID        530..565
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DISULFID        534..570
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DISULFID        545..555
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DISULFID        880..917
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00098"
FT   DISULFID        905..919
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00098"
SQ   SEQUENCE   1577 AA;  172883 MW;  0DB6FCC202F80EEA CRC64;
     MRGQAAAPGP IWILAPLLLL LLLLGRWARA ASGADIGPGT EQCTTLVQGK FFGYFSAAAV
     FPANASRCSW TLRNPDPRRY TLYMKVAKAP APCSGPGRVR TYQFDSFLES TRTYLGVESF
     DEVLRLCDPS APLAFLQASK QFLQMQRQQP PQDGDLGPQG SGDDFSVEYL VVGNRNPSHA
     ACQMLCRWLD ACLAGSRSSH PCGIMQTPCA CLGGEAGDTA SSPLVPRGDV CLRDGVAGGP
     ENCLTSLTQD RGGHGSAGGW KLWSLWGECT RDCGGGLQTR TRTCSPTLGV EGRGCEGVLE
     EGRLCNRKAC GPTGRTSSRS QSLRSTDARR REEFGDELQQ FGFPSPQTGD PAAEEWSPWS
     VCSSTCGEGW QTRTRFCVSS SYSTQCSGPL REQRLCNNSA VCPVHGAWDE WSPWSLCSST
     CGRGFRDRTR TCRPPQFGGN PCEGPEKQTK FCNIALCPGR AVDGNWNEWS SWSTCSASCS
     QGRQQRTREC NGPSYGGAEC QGHWVETRDC FLQQCPVDGK WQAWASWGSC SVTCGGGSQR
     RERVCSGPFF GGAACQGPQD EYRQCGAQRC PEPHEICDED NFGAVVWKET PAGEVAAVRC
     PRNATGLILR RCELDEEGIA FWEPPTYIRC VSIDYRNIQM MTREHLAKAQ RGLPGEGVSE
     VIQTLLEISQ DGTSYSGDLL STIDVLRNMT EIFRRAYYSP TPGDVQNFVQ IISNLLAEEN
     RDKWEEAQLM GPNAKELFRL VEDFVDVIGF RMKDLRDAYQ VTDNLVLSIH KLPASGATDI
     SFPMKGWRAT GDWAKVPEDR VTVSKSVFST GLAEADDSSV FVVGTVLYRN LGSFLALQRN
     TTVLNSKVIS VTVKPPPRSL LTPLEIEFAH MYNGTTNQTC ILWDETDGPS SSAPPQLGPW
     SWRGCRTVPL DALRTRCLCD RLSTFAILAQ LSADATMDKV TVPSVTLIVG CGVSSLTLLM
     LVIIYVSVWR YIRSERSVIL INFCLSIISS NALILIGQTQ TRNKVVCTLV AAFLHFFFLS
     SFCWVLTEAW QSYMAVTGRL RSRLVRKRFL CLGWGLPALV VAISVGFTKA KGYSTMNYCW
     LSLEGGLLYA FVGPAAAVVL VNMVIGILVF NKLVSKDGIT DKKLKERAGA SLWSSCVVLP
     LLALTWMSAV LAVTDRRSAL FQILFAVFDS LEGFVIVMVH CILRREVQDA VKCRVVDRQE
     EGNGDSGGSF QNGHAQLMTD FEKDVDLACR SVLNKDIAAC RTATITGTFK RPSLPEEEKM
     KLAKGPPPTF NSLPANVSKL HLHGSPRYPG GPLPDFPNHS LTLKKDKAPK SSFIGDGDIF
     KKLDSELSRA QEKALDTSYV ILPTATATLR PKPKEEPKYS INIDQMPQTR LIHLSMAPDA
     SFPTRSPPAR EPPGGAPPEV PPVQPPPPPP PPPPPQQPIP PPPSLEPAPP SLGDTGEPSA
     HPGPSSGAGT KNENVATLSV SSLERRKSRY AELDFEKIMH TRKRHQDMFQ DLNRKLQHAA
     EKEKEVPGVD NKPEKQQTPN KRAWESLRKP HGTPAWVKKE LEPLPPSPLE LRSVEWEKAG
     ATIPLVGQDI IDLQTEV
//
